For example, our group has shown that the subgroup of high-grade serous ovarian carcinomas expressing mutant p53 protein exhibited significantly prolonged overall disease-free survival as compared with carcinomas harboring p53 null mutations (Wojnarowicz et al., 2012). The gene discussed is TP53; the disease is carcinoma.